Politics & PolicyYesterday
Peptide Lobby Wins FDA Panel Vote Over Agency Scientists' Objections
The Pharmacy Compounding Advisory Committee voted 9-4 to add 20 peptide substances to the permitted compounding list, overriding internal FDA safety warnings.
